[Role of cyclooxygenase-2 in pulmonary microcirculation disorder in rats with acute pancreatitis]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Mar;38(2):250-4.
[Article in Chinese]

Abstract

Objective: To identify the expression of Cyclooxygenase-2 (Cox-2) in lung tissues and its potential role in pulmonary microcirculation disorder in rats with acute pancreatitis.

Methods: The acute hemorrhagic and necrotic pancreatitis (AHNP) model was induced by the standard retrograde infusion of bilio-pancreatic duct with 4% sterile sodium taurocholate solution in Sprague-Dawley rats. The rats were randomly allocated into sham surgery group, AHNP group, and prophylactic celecoxib treated AHNP (C+ AHNP) group. The HE, phosphotungstic acid hematain (PTAH) and immunohistochemistrical (IHC) staining were employed to assess the dynamical alterations and interrelations of the histopathology, density of micro-thrombus and Cox-2 expression of lung tissue respectively over a time course of 3, 6, 12 and 24 hours.

Results: A significant and progressing increase in histopathologic scoring and Cox-2 expression in the lung tissues were found. There was a positive correlation between the Cox-2 expression and the histopathological scoring. A significant increase of pulmonary micro-thrombosis was detected at the early stage of the rat AHNP induced by sodium taurocholate, and the density of micro-thrombus was positively associated with the histopathological scoring. The prophylactic treatment with celecoxib, a highly selective inhibitor of Cox-2, attenuated the changes in histopathology, pulmonary micro-thrombosis and Cox-2 expression (P < 0.05). The down-regulated intensity of the Cox-2 expression by celecoxib was positively correlated with the improvement of the histopathology injury, but not with the change of the pulmonary micro-thrombosis.

Conclusion: The pulmonary microcirculation dysfunction caused by micro-thrombosis is an early event or even an enabler of the development of APALI. The over-expression of Cox-2 may have promoted the procoagulant activity which plays a key role in the development of pulmonary thrombus.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Celecoxib
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Lung / blood supply*
  • Lung / drug effects
  • Lung / enzymology*
  • Lung / pathology
  • Lung Diseases / complications*
  • Lung Diseases / enzymology*
  • Lung Diseases / pathology
  • Lung Diseases / physiopathology
  • Male
  • Microcirculation* / drug effects
  • Pancreatitis, Acute Necrotizing / complications*
  • Pyrazoles / pharmacology
  • Rats
  • Sulfonamides / pharmacology
  • Thrombosis / complications
  • Thrombosis / enzymology
  • Thrombosis / pathology

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • Celecoxib